Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FXQK4
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,020
Award facts
- Contract value 100% obligated
- $16,020.05 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $16,020.05 delivery order to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 ml pen injectables on December 12, 2025, with a completion date of December 15, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The contract carries no set-aside designation, reflecting open competition for this pharmaceutical supply requirement. Performance will be executed from AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania.
This delivery order falls within AmerisourceBergen's comprehensive pharmaceutical supply agreement with the Defense Logistics Agency's Medical Supply Chain, which enables the distributor to supply a wide range of brand-name and generic medications to support military healthcare programs globally. Dupixent (dupilumab) is a biologic immunosuppressant used to treat conditions such as atopic dermatitis, asthma, and chronic rhinosinusitis with nasal polyps. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen has demonstrated consistent capability in fulfilling federal medical supply requirements through its extensive portfolio of delivery orders across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26FXQK4?
SPE2DR26FXQK4 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 12, 2025.
How much is contract SPE2DR26FXQK4 worth?
The government has obligated $16,020 on SPE2DR26FXQK4.
Is contract SPE2DR26FXQK4 an order under another contract?
Yes. SPE2DR26FXQK4 is a delivery order under SPE2DR25D3004, an indefinite delivery contract.
Was contract SPE2DR26FXQK4 competed?
The extent of competition for SPE2DR26FXQK4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award